Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Regeneron loses bid to block Amgen's Eylea biosim, sinking shares
After a federal judge blocked the entry of two biosimilars for Eylea, the same judge has rejected Regeneron's bid to block Amgen’s Eylea knockoff.
Kevin Dunleavy
Sep 24, 2024 10:32am
Sandoz, Liquidia score $137M win in United generic lawsuit
Sep 16, 2024 2:54pm
With Sandoz contract expiring, GSK will close plant in UK
Sep 9, 2024 11:53am
Sandoz raises guidance after another quarter of sales growth
Aug 9, 2024 7:50am
Humira's market share slips as biosimilars start to catch on
Jul 12, 2024 11:51am
Evotec, Sandoz expand biosimilar production pact inked last year
Jul 9, 2024 8:25am
